From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: The discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis
Keywords: ائوزینوفیل شیمیایی; CCR3 antagonist; BMS-639623; Development candidate; Ab initio; Eosinophil chemotaxis; Asthma; Conformational analysis; Acyclic scaffold